These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34087231)

  • 1. Expression profiling of RTL1 in human breast cancer tissues and cell lines.
    Mahmoudi AR; Ghods R; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Safaei M; Balaei Goli L; Vafaei S; Katouzian L; Soltanghoraei H; Shekarabi M; Zarnani AH
    Exp Mol Pathol; 2021 Aug; 121():104654. PubMed ID: 34087231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
    Aleskandarany MA; Sonbul S; Surridge R; Mukherjee A; Caldas C; Diez-Rodriguez M; Ashankyty I; Albrahim KI; Elmouna AM; Aneja R; Martin SG; Ellis IO; Green AR; Rakha EA
    Br J Cancer; 2017 Oct; 117(8):1176-1184. PubMed ID: 28829761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.
    Feng L; Huang S; An G; Wang G; Gu S; Zhao X
    Int J Oncol; 2019 Nov; 55(5):1003-1018. PubMed ID: 31545416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
    Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
    Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
    Yang Q; Ji G; Li J
    Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
    Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
    Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.
    Giaginis C; Sampani A; Kotta-Loizou I; Giannopoulou I; Danas E; Politi E; Tsourouflis G; Kouraklis G; Patsouris E; Keramopoulos A; Nakopoulou L; Theocharis S
    Pathol Oncol Res; 2018 Jul; 24(3):631-640. PubMed ID: 28808873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
    Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
    Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
    Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
    Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of LncRNA-GACAT3 with MRI features of breast cancer and its molecular mechanism.
    Hu H; Wang Y; Zhang T; Zhang C; Liu Y; Li G; Zhou D; Lu S
    J BUON; 2019; 24(6):2377-2384. PubMed ID: 31983109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas.
    Irini T; Paraskevi A; Ioanna G; Christos P; Lydia N
    APMIS; 2013 Sep; 121(9):797-805. PubMed ID: 23278310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
    Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
    Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POPDC1 is suppressed in human breast cancer tissues and is negatively regulated by EGFR in breast cancer cell lines.
    Amunjela JN; Tucker SJ
    Cancer Lett; 2017 Oct; 406():81-92. PubMed ID: 28807821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
    Shao W; Kuhn C; Mayr D; Ditsch N; Kailuwait M; Wolf V; Harbeck N; Mahner S; Jeschke U; Cavaillès V; Sixou S
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2535-2544. PubMed ID: 34085098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?
    Khabaz MN
    Asian Pac J Cancer Prev; 2014; 15(19):8395-400. PubMed ID: 25339035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
    Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.